Key result
The diacylglycerol-mimetic 4βPMA enhances voltage-dependent opening of HCN pacemaker channels via sequential activation of PKC and diacylglycerol kinase coupled with upregulation of MAPK and phospholipase A2.
Population
Xenopus oocytes expressing wild-type and mutant hyperpolarization-activated, cyclic nucleotide-regulated…
Comparison
4beta-phorbol-12-myristate-13-acetate and other… vs Vehicle control or inactive stereoisomer 4alphaPMA
Design
Preclinical
Authors
Loading...
Identifies novel I(H) modulation by phospholipids; leaves open roles in neuronal and cardiac pacemaking.
HCN pacemaker channel activation is modulated by acidic lipids (phosphatidic acid and arachidonic acid) downstream of diacylglycerol kinase and phospholipase A2, revealing a novel lipid signaling pathway for I(H) regulation.
Fogle et al. (2007) studied this question. 4β-phorbol-12-myristate-13-acetate (4βPMA) vs. Vehicle (DMSO) or 4αPMA was evaluated on Voltage-dependent opening of HCN channels (shift in V1/2). The diacylglycerol-mimetic 4βPMA enhances voltage-dependent opening of HCN pacemaker channels via sequential activation of PKC and diacylglycerol kinase coupled with upregulation of MAPK and phospholipase A2.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: